Contract facts
FederalCLIN FUNDING is a federal award for Dla Land At Aberdeen held by Raytheon Company. Estimated value $72M ($62M obligated). Current period of performance ends Jul 31, 2028. Place of performance: MCKINNEY, TX.
Recompete timing
PublicCurrent PoP ends Jul 31, 2028 (711 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jan 31, 2027.
Incumbent footprint
Public recordRaytheon Company — $8.4B obligated across 383 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract SPRBL123F0055?
SPRBL123F0055 (CLIN funding) is a Dla Land At Aberdeen award with an estimated value of $72M, currently held by Raytheon Company. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is SPRBL1-23-F-0055?
SPRBL1-23-F-0055 is the dashed form of PIID SPRBL123F0055 (CLIN funding), held by Raytheon Company. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded SPRBL123F0055?
Dla Land At Aberdeen awarded SPRBL123F0055 to Raytheon Company.
Who is the incumbent on SPRBL123F0055?
Raytheon Company is the incumbent with $8.4B across 383 related awards in SCOUT’s public footprint. The current period of performance ends Jul 31, 2028.
When does Raytheon Company’s SPRBL123F0055 come up for recompete?
SCOUT tracks a period-of-performance end of Jul 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.